Tara Smith 6/14/22 Tara Smith 6/14/22 MLD presenting at AAIC 2022 Read More Tara Smith 6/4/22 Tara Smith 6/4/22 MLD's newest manuscript describes the metabolism and tissue distribution of PPI-1011 Read More Shawn Ritchie 4/1/22 Shawn Ritchie 4/1/22 MLD on location in Wilmington Delaware Read More Shawn Ritchie 11/1/21 Shawn Ritchie 11/1/21 MLD Obtains Analytical Cannabis License from Health Canada Read More Tara Smith 9/21/21 Tara Smith 9/21/21 World Alzheimer's Day 2021 Read More Tara Smith 7/6/21 Tara Smith 7/6/21 MLD's latest publication estimating the prevalence and incidence of RCDP Read More Kaeli Knudsen 4/29/21 Kaeli Knudsen 4/29/21 MLD announces new collaboration with Dr. Marie-Eve Tremblay at the University of Victoria Read More Tara Smith 2/26/21 Tara Smith 2/26/21 Rare Disease Day 2021 Read More Tara Smith 2/2/21 Tara Smith 2/2/21 Research Collaboration with Montreal Heart Institute Research Center Read More Tara Smith 10/23/20 Tara Smith 10/23/20 MLD attending World Orphan Drug Congress Read More Shawn Ritchie 8/19/20 Shawn Ritchie 8/19/20 MLD to build new GLP laboratory facilities in Saskatoon Read More Shawn Ritchie 7/21/20 Shawn Ritchie 7/21/20 MLD creates spin-out company GraySpace Therapeutics Read More Tara Smith 7/8/20 Tara Smith 7/8/20 Med-Life Discoveries awarded grant by The Michael J. Fox Foundation Read More Tara Smith 2/28/20 Tara Smith 2/28/20 Rare Disease Day 2020! Read More Tara Smith 2/10/20 Tara Smith 2/10/20 Natural History Study Update Read More Shawn Ritchie 12/21/19 Shawn Ritchie 12/21/19 Landmark Plasmalogen Precursor Paper Published Read More Shawn Ritchie 12/17/19 Shawn Ritchie 12/17/19 MLD and BML (Japan) announce distribution agreement for PanaSee™ pancreatic cancer screening test kits. Read More Shawn Ritchie 12/9/19 Shawn Ritchie 12/9/19 MLD on location at Plasmalogen Precursor formulation site Read More Tara Smith 11/28/19 Tara Smith 11/28/19 MLD to attend CTAD 2019 Read More Shawn Ritchie 10/31/19 Shawn Ritchie 10/31/19 MLD and Laval University collaborators publish key Parkinson's disease plasmalogen paper Read More Newer Posts Older Posts
Tara Smith 6/4/22 Tara Smith 6/4/22 MLD's newest manuscript describes the metabolism and tissue distribution of PPI-1011 Read More
Shawn Ritchie 11/1/21 Shawn Ritchie 11/1/21 MLD Obtains Analytical Cannabis License from Health Canada Read More
Tara Smith 7/6/21 Tara Smith 7/6/21 MLD's latest publication estimating the prevalence and incidence of RCDP Read More
Kaeli Knudsen 4/29/21 Kaeli Knudsen 4/29/21 MLD announces new collaboration with Dr. Marie-Eve Tremblay at the University of Victoria Read More
Tara Smith 2/2/21 Tara Smith 2/2/21 Research Collaboration with Montreal Heart Institute Research Center Read More
Shawn Ritchie 8/19/20 Shawn Ritchie 8/19/20 MLD to build new GLP laboratory facilities in Saskatoon Read More
Shawn Ritchie 7/21/20 Shawn Ritchie 7/21/20 MLD creates spin-out company GraySpace Therapeutics Read More
Tara Smith 7/8/20 Tara Smith 7/8/20 Med-Life Discoveries awarded grant by The Michael J. Fox Foundation Read More
Shawn Ritchie 12/21/19 Shawn Ritchie 12/21/19 Landmark Plasmalogen Precursor Paper Published Read More
Shawn Ritchie 12/17/19 Shawn Ritchie 12/17/19 MLD and BML (Japan) announce distribution agreement for PanaSee™ pancreatic cancer screening test kits. Read More
Shawn Ritchie 12/9/19 Shawn Ritchie 12/9/19 MLD on location at Plasmalogen Precursor formulation site Read More
Shawn Ritchie 10/31/19 Shawn Ritchie 10/31/19 MLD and Laval University collaborators publish key Parkinson's disease plasmalogen paper Read More
